Dergiler / Eurasian Journal of Medical Investigation / 2021 / Cilt: 5 - Sayı: 3

Predictive Importance of Vitamin D on Response toNeoadjuvant Chemotherapy in Turkish Patients with LocallyAdvanced Hormone Receptor Positive Breast Cancer

Sayfa
388–393
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This may be explained with vitamin D receptor polymorphism in different ethnicities whichshould be evaluated in future studies in terms of pathologic response to neoadjuvant chemotherapy.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: To investigate the relationship between the level of vitamin D with pathological response rates to neoad juvant chemotherapy in breast cancer patients.
📊
Temel Bulgular & Veri:Methods: The pathological responses of patients treated with neoadjuvant chemotherapy for locally advanced breastcancer regarding Miller-Payne grading system were noted as ≤90% and >90% response.
💡
Sonuç & Katkı:This may be explained with vitamin D receptor polymorphism in different ethnicities whichshould be evaluated in future studies in terms of pathologic response to neoadjuvant chemotherapy.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: To investigate the relationship between the level of vitamin D with pathological response rates to neoad juvant chemotherapy in breast cancer patients. Methods: The pathological responses of patients treated with neoadjuvant chemotherapy for locally advanced breastcancer regarding Miller-Payne grading system were noted as ≤90% and >90% response. Vitamin D deficiency was de fined as 90 to neoadjuvant chemotherapy, respectively. In univariate analysis,tumor size, menopause status, and histologic grade were found to be statistically significant for pathological response.In multivariate analysis, progesteron receptor positivity, premenopause, and higher tumor diameter were associatedwith decreasing pathologic response. The level of vitamin D was not statistically significant on pathological responseto neoadjuvant chemotherapy. Conclusion: The level of vitamin D level was not associated with pathologic response rates to neoadjuvant chemother apy in Turkish population. This may be explained with vitamin D receptor polymorphism in different ethnicities whichshould be evaluated in future studies in terms of pathologic response to neoadjuvant chemotherapy.

🔖

Bu Makaleye Atıf Yap

ATÇI, M. M., ÇEKİN, R. (2022). Predictive Importance of Vitamin D on Response toNeoadjuvant Chemotherapy in Turkish Patients with LocallyAdvanced Hormone Receptor Positive Breast Cancer. Eurasian Journal of Medical Investigation, Cilt: 5 - Sayı: 3, 388–393. https://ajindex.com/articles/508609

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019
  2. 7–34. [CrossRef] 2. Mieog JS, van der Hage JA, van de Velde CJ. Preoperative chemotherapy for women with operable breast cancer. Cochrane Database Syst Rev 2007
  3. CD005002. [CrossRef] 3. Ogston KN, Miller ID, Payne S, Hutcheon AW, Sarkar TK, Smith I, et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast 2003
  4. 320–7. [CrossRef] 4. von Minckwitz G, Untch M, Blohmer JU, Costa SD, Eidtmann H, Fasching PA, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 2012
  5. 1796–804. [CrossRef] 5. Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 2014
  6. 164–72. [CrossRef] 6. Arici S, Karyagar SS, Karyagar S, Geredeli C, Cekin R, Seçmeler Ş, et al. The predictive role of metabolic tumor volume on no response to neoadjuvant chemotherapy in patients with breast cancer. J Oncol Pharm Pract 2020
  7. 1415–20. [CrossRef] 7. Arici S, Sengiz Erhan S, Geredeli C, Cekin R, Sakin A, Cihan S. The clinical importance of androgen receptor status in response to neoadjuvant chemotherapy in Turkish patients with local and locally advanced breast cancer. Oncol Res Treat 2020
  8. 435–40. [CrossRef] 8. Liedtke C, Mazouni C, Hess KR, André F, Tordai A, Mejia JA, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol 2008
  9. 1275–81. [CrossRef] 9. Hemida MA, AbdElmoneim NA, Hewala TI, Rashad MM, Abdaallah S. Vitamin D receptor in breast cancer tissues and its relation to Estrogen Receptor Alpha (ER-α) gene expression and Serum 25-hydroxyvitamin D levels in Egyptian breast cancer patients: a case-control study. Clin Breast Cancer 2019
  10. 407–14. [CrossRef] 10. Kanstrup C, Teilum D, Rejnmark L, Bigaard JV, Eiken P, Kroman N, et al. 25-Hydroxyvitamin D at time of breast cancer diagnosis and breast cancer survival. Breast Cancer Res Treat 2020
  11. 699–708. [CrossRef] 11. Yao S, Kwan ML, Ergas IJ, Roh JM, Cheng TD, Hong CC, et al. Association of serum level of vitamin D at diagnosis with breast cancer survival: a case-cohort analysis in the pathways study. JAMA Oncol 2017
  12. 351–7. [CrossRef] 12. Ha